Various early studies, mostly in rodents, have shown promise in this area and future research is sure to lead to new discoveries, which will in turn trigger others
Does Melanotan 2 have research applications for weight loss
doi: 10.2337/dc07-0141 Summary Keywords bariatric surgery, type 2 diabetes mellitus, recurrent weight gain, glucagon-like peptide-1, conversional surgery Citation Xiao H, Du Y, Tan Y and Ren Y (2024) Prognosticating post-bariatric surgery outcomes and management of postoperative recurrent weight gain and diabetes recurrence
Dalsgaard NB, Brnden A, Vilsbll T et al
1 Introduction Psoriasis (PsO) is a chronic, immune-mediated inflammatory skin disorder affecting 23% of the global population ( In parallel with this evolving disease concept, growing evidence points to a complex immunometabolic interplay linking dysregulated glucose metabolism, incretin biology, and chronic inflammation in PsO ( Within this framework, incretins particularly glucagon-like peptide-1 (GLP-1) have emerged as key immunometabolic regulators rather than merely glucose-lowering hormones
